393 related articles for article (PubMed ID: 17182683)
1. Multiple amino acid substitutions in hemagglutinin are necessary for wild-type measles virus to acquire the ability to use receptor CD46 efficiently.
Tahara M; Takeda M; Seki F; Hashiguchi T; Yanagi Y
J Virol; 2007 Mar; 81(6):2564-72. PubMed ID: 17182683
[TBL] [Abstract][Full Text] [Related]
2. Recombinant wild-type measles virus containing a single N481Y substitution in its haemagglutinin cannot use receptor CD46 as efficiently as that having the haemagglutinin of the Edmonston laboratory strain.
Seki F; Takeda M; Minagawa H; Yanagi Y
J Gen Virol; 2006 Jun; 87(Pt 6):1643-1648. PubMed ID: 16690929
[TBL] [Abstract][Full Text] [Related]
3. Use of site-specific mutagenesis and monoclonal antibodies to map regions of CD46 that interact with measles virus H protein.
Hsu EC; Sabatinos S; Hoedemaeker FJ; Rose DR; Richardson CD
Virology; 1999 Jun; 258(2):314-26. PubMed ID: 10366568
[TBL] [Abstract][Full Text] [Related]
4. Contributions of matrix and large protein genes of the measles virus edmonston strain to growth in cultured cells as revealed by recombinant viruses.
Tahara M; Takeda M; Yanagi Y
J Virol; 2005 Dec; 79(24):15218-25. PubMed ID: 16306593
[TBL] [Abstract][Full Text] [Related]
5. Altered interaction of the matrix protein with the cytoplasmic tail of hemagglutinin modulates measles virus growth by affecting virus assembly and cell-cell fusion.
Tahara M; Takeda M; Yanagi Y
J Virol; 2007 Jul; 81(13):6827-36. PubMed ID: 17442724
[TBL] [Abstract][Full Text] [Related]
6. Structural and functional studies of the measles virus hemagglutinin: identification of a novel site required for CD46 interaction.
Patterson JB; Scheiflinger F; Manchester M; Yilma T; Oldstone MB
Virology; 1999 Mar; 256(1):142-51. PubMed ID: 10087234
[TBL] [Abstract][Full Text] [Related]
7. Differential receptor usage by measles virus strains.
Bartz R; Firsching R; Rima B; ter Meulen V; Schneider-Schaulies J
J Gen Virol; 1998 May; 79 ( Pt 5)():1015-25. PubMed ID: 9603316
[TBL] [Abstract][Full Text] [Related]
8. Efficiency of measles virus entry and dissemination through different receptors.
Schneider U; von Messling V; Devaux P; Cattaneo R
J Virol; 2002 Aug; 76(15):7460-7. PubMed ID: 12097558
[TBL] [Abstract][Full Text] [Related]
9. Effect of the alterations in the fusion protein of measles virus isolated from brains of patients with subacute sclerosing panencephalitis on syncytium formation.
Ayata M; Shingai M; Ning X; Matsumoto M; Seya T; Otani S; Seto T; Ohgimoto S; Ogura H
Virus Res; 2007 Dec; 130(1-2):260-8. PubMed ID: 17825451
[TBL] [Abstract][Full Text] [Related]
10. High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus.
Anderson BD; Nakamura T; Russell SJ; Peng KW
Cancer Res; 2004 Jul; 64(14):4919-26. PubMed ID: 15256464
[TBL] [Abstract][Full Text] [Related]
11. Reduced ability of hemagglutinin of the CAM-70 measles virus vaccine strain to use receptors CD46 and SLAM.
Kato S; Ohgimoto S; Sharma LB; Kurazono S; Ayata M; Komase K; Takeda M; Takeuchi K; Ihara T; Ogura H
Vaccine; 2009 Jun; 27(29):3838-48. PubMed ID: 19490984
[TBL] [Abstract][Full Text] [Related]
12. Selectively receptor-blind measles viruses: Identification of residues necessary for SLAM- or CD46-induced fusion and their localization on a new hemagglutinin structural model.
Vongpunsawad S; Oezgun N; Braun W; Cattaneo R
J Virol; 2004 Jan; 78(1):302-13. PubMed ID: 14671112
[TBL] [Abstract][Full Text] [Related]
13. A single amino acid change in the hemagglutinin protein of measles virus determines its ability to bind CD46 and reveals another receptor on marmoset B cells.
Hsu EC; Sarangi F; Iorio C; Sidhu MS; Udem SA; Dillehay DL; Xu W; Rota PA; Bellini WJ; Richardson CD
J Virol; 1998 Apr; 72(4):2905-16. PubMed ID: 9525611
[TBL] [Abstract][Full Text] [Related]
14. Interaction of measles virus (Hallé strain) with CD46: evidence that a common binding site on CD46 facilitates both CD46 downregulation and MV infection.
Lecouturier V; Rizzitelli A; Fayolle J; Daviet L; Wild FT; Buckland R
Biochem Biophys Res Commun; 1999 Oct; 264(1):268-75. PubMed ID: 10527876
[TBL] [Abstract][Full Text] [Related]
15. Retargeted oncolytic measles strains entering via the EGFRvIII receptor maintain significant antitumor activity against gliomas with increased tumor specificity.
Allen C; Vongpunsawad S; Nakamura T; James CD; Schroeder M; Cattaneo R; Giannini C; Krempski J; Peng KW; Goble JM; Uhm JH; Russell SJ; Galanis E
Cancer Res; 2006 Dec; 66(24):11840-50. PubMed ID: 17178881
[TBL] [Abstract][Full Text] [Related]
16. A novel amino acid position in hemagglutinin glycoprotein of measles virus is responsible for hemadsorption and CD46 binding.
Li L; Qi Y
Arch Virol; 2002 Apr; 147(4):775-86. PubMed ID: 12038687
[TBL] [Abstract][Full Text] [Related]
17. Interactions between the ectodomains of haemagglutinin and CD46 as a primary step in measles virus entry.
Devaux P; Loveland B; Christiansen D; Milland J; Gerlier D
J Gen Virol; 1996 Jul; 77 ( Pt 7)():1477-81. PubMed ID: 8757989
[TBL] [Abstract][Full Text] [Related]
18. Measles virus selectively blind to signaling lymphocyte activation molecule as a novel oncolytic virus for breast cancer treatment.
Sugiyama T; Yoneda M; Kuraishi T; Hattori S; Inoue Y; Sato H; Kai C
Gene Ther; 2013 Mar; 20(3):338-47. PubMed ID: 22717740
[TBL] [Abstract][Full Text] [Related]
19. A 3D model for the measles virus receptor CD46 based on homology modeling, Monte Carlo simulations, and hemagglutinin binding studies.
Mumenthaler C; Schneider U; Buchholz CJ; Koller D; Braun W; Cattaneo R
Protein Sci; 1997 Mar; 6(3):588-97. PubMed ID: 9070441
[TBL] [Abstract][Full Text] [Related]
20. Measles viruses on throat swabs from measles patients use signaling lymphocytic activation molecule (CDw150) but not CD46 as a cellular receptor.
Ono N; Tatsuo H; Hidaka Y; Aoki T; Minagawa H; Yanagi Y
J Virol; 2001 May; 75(9):4399-401. PubMed ID: 11287589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
